doi: 10.3389/fmed.2026.1730795 Received 23 October 2025 Revised 06 March 2026 Accepted 23 March 2026 Published 02 April 2026 Corrected 05 June 2026 Volume 13 - 2026 Edited by Andrea Tinelli, Veris Delli Ponti Hospital, Italy Reviewed by Feng Zhang, Nanjing University of Chinese Medicine, China Minghong Sun, Southwest University, China Updates Copyright 2026 Lv, Li, Ding and Kuang
However, pharmacovigilance data from the WHO's global adverse drug reaction database showed disproportionate reporting of eating disorder adverse events across all three major GLP-1 medications
A case report published in the Journal of Innovations in Clinical Neuroscience noted that a patient who was treated with Ozempic for Type 2 diabetes started experiencing symptoms of major depression within four weeks of starting the medication
Insulin resistance , which affects up to 80% of women with PCOS, traps your body in a destructive cycle